THE MADAGASCAR INTERNATIONAL COOPERATIVE BIODIVERSITY GROUP: BACKGROUND AND HISTORY David Kingston...
-
Upload
reynard-gilbert -
Category
Documents
-
view
214 -
download
0
Transcript of THE MADAGASCAR INTERNATIONAL COOPERATIVE BIODIVERSITY GROUP: BACKGROUND AND HISTORY David Kingston...
THE MADAGASCAR INTERNATIONAL
COOPERATIVE BIODIVERSITY GROUP:
BACKGROUND AND HISTORY
David Kingston Department of Chemistry
Virginia Polytechnic Institute & State UniversityWeb: www .kingston.chem.vt.edu
Natural Products as Drugs and Drug Leads
WHO estimates that ~80% of the world’s population use traditional medicine.
Between 1983 and 1994 41% of new approved drugs had natural products as their source.
David J. Newman, et al. Nat. Prod. Rep., 2000, 17, 215-234
Gordon M. Cragg, et al. J. Nat. Prod., 1997, 60, 52-60
6%
26%
9%
59%
Natural Product Drugs Modified Natural Product Drugs Synthetic Drugs Based on Natural Product Models Synthetic Drugs
1986-1990 1991-1995 1996-20010
1000
2000
# of
issu
ed p
aten
ts
microbial
plant
total
694
16550 91
315
1153
448
969
2580
MORE REASONS FOR FAITH IN NATURAL PRODUCTS
61% of all the new drugs introduced Worldwide during 1981-2002 can be traced to or were inspired by Natural Products. Newman, Cragg, Snader 2003 J Nat Prod 66:1022
Synthetic Compound from combinatorial chemistry
Natural Products
Drugs
Feher and Schmidt 2003 J Chem Inf Comput Sci 43:218
Chiral ctr = 0.4
Chiral ctr = 6.2
Chiral ctr = 2.3
NP are more diverse than synthetics
SOME IMPORTANT ANTICANCER NATURAL PRODUCTS
TAXOL, from Taxus brevifolia
O
OH
HHO
OCOC6H5
AcO
O
O
O
C6H5
NH
OH
C6H5
O
OAc
13
107
2
■Treatment for ovarian and breast cancer■Also used in stents to prevent restenosis■Major drug, with sales of over one billion dollars/year
WHY NATURAL PRODUCTS?
NATURAL PRODUCTS CAN FORM THE BASIS OF NEW COMPOUND LIBRARIESR. Breinbauer et al, Angew. Chem. Int. Ed. 2002, 41, 2878
EXAMPLE: THE HALICHONDRINSM. J. Yu 224th ACS National Meeting, Boston, MA, August 21, 2001, Abstract MEDI 238.
O
O
O
O
O
O
OO
O
OO
O
OO
O
O
HO
HO
HO
H
H
H
H
H H
H H
H
H
H
H
H
DRUG DISCOVERY THROUGH NATURAL PRODUCTS
COLLECT LARGE NUMBERS OF PLANT, MARINE, OR MICROBIAL SPECIES
PREPARE EXTRACTS AND TEST IN RELEVANT BIOASSAY SYSTEMS
RECOLLECT OR REFERMENT ACTIVE SPECIES AND ISOLATE ACTIVE COMPOUNDS BY A BIOASSAY-DIRECTED FRACTIONATION
DETERMINE STRUCTURES OF BIOACTIVE COMPOUNDS
CARRY OUT ADDITIONAL BIOLOGICAL TESTING
THE PROBLEM OF BIODIVERSITY LOSS
DRUG DISCOVERY REQUIRES RANDOM SCREENING OF THOUSANDS OF SPECIES “YOU HAVE TO KISS A LOT OF FROGS TO FIND A PRINCE”
TROPICAL RAINFORESTS COVER ONLY 8% OF THE EARTH’S SURFACE BUT HOLD 50% OF ITS PLANTS
TROPICAL FORESTS ARE DISAPPEARING FAST; DOWN FROM 16% OF EARTH’S LAND SURFACE IN 1950 TO LESS THAN 8% TODAY
TROPICAL REEFS ARE ALSO UNDER THREAT
LOSS OF RAINFOREST MEANS THE POTENTIAL LOSS OF CURES FOR CANCER, AIDS, ETC.
THE MADAGASCAR ICBG APPROACH TO BIODIVERSITY CONSERVATIONCARRY OUT BIOPROSPECTING WITH
FULL INFORMED CONSENT OF ALL PARTIES
PARTNER WITH PHARMACEUTICAL AND AGROCHEMICAL COMPANIES
SINCE BIODIVERSITY LOSS IS CLOSELY ASSOCIATED WITH POVERTY, COMBINE BIOPROSPECTING WITH ECONOMIC DEVELOPMENT ACTIVITIES
COMMIT TO RETURN ANY ROYALTY PAYMENTS IN PART TO THE HOST COUNTRY IN COMPENSATION FOR USE OF ITS BIODIVERSITY
HOW AND WHERE TO DO THIS?
1992 NATIONAL INSTITUTES OF HEALTH INVITED SCIENTISTS TO COMPETE FOR FUNDS TO DO DRUG DISCOVERY AND BIODIVERSITY CONSERVATION
1993-1998 VIRGINIA TECH PROPOSAL FUNDED TO DO WORK IN SURINAME
1998-2003 RENEWAL PROPOSAL FUNDED TO DO WORK IN SURINAME AND MADAGASCAR
2003-2008 THIRD ROUND OF FUNDING AWARDED FOR WORK IN MADAGASCAR
MADAGASCAR GROUP STRUCTURE VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY
CENTRAL OPERATIONS OFFICE MISSOURI BOTANICAL GARDEN
BOTANICAL COLLECTIONS, BIODIVERSITY SURVEY CONSERVATION INTERNATIONAL
ECONOMIC DEVELOPMENT, BIODIVERSITY CONSERVATIONCENTRE NATIONAL D’APPLICATION ET DES RECHERCHES PHARMACEUTIQUES PLANT EXTRACTS, ANTIMALARIAL FRACTIONATION
CENTRE NATIONAL DE RECHERCHES SUR L’ENVIRONNEMENT MARINE COLLECTION, MICROBIAL ISOLATIONS
EISAI RESEARCH INSTITUTE BIOASSAY, DRUG DISCOVERY AND DEVELOPMENT
DOW AGROSCIENCES AGROCHEMICAL DISCOVERY AND DEVELOPMENT
VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY BIOASSAY AND ANTICANCER DRUG DISCOVERY
GOALS OF THE MADAGASCAR ICBG PROGRAM
TO INTEGRATE THE PROCESS OF DRUG AND AGROCHEMICAL DISCOVERY FROM NATURAL PRODUCTS WITH CONSERVATION OF BIODIVERSITY AND SUSTAINABLE ECONOMIC DEVELOPMENT, WHILE PROVIDING FINANCIAL BENEFITS TO MADAGASCAR AND ITS PEOPLE
MADAGASCAR
WHY MADAGASCAR?
Madagascar is a prime source of biodiversity. Madagascar is one of the highest priority “Biodiversity Hotspots”Home to 25% of the plant species in the African regionApproximately 80% of species are endemicGreat ecosystem diversityWork is urgent, since much of the country has been deforested
SCIENTIFIC DEVELOPMENT IN MADAGASCAR
Laboratories at CNARP have been equipped to prepare plant extracts
Laboratories at CNARP have been equipped and personnel trained to carry out antimalarial bioassays
Facilities at CNRO (Nosy be) are being equipped to carry out marine collections
Personnel at CNRE will be trained in microbial isolations
Data handling infrastructure has been expanded
ECONOMIC DEVELOPMENT IN MADAGASCAR
SMALL-SCALE ECONOMIC DEVELOPMENT PROJECTS IN THE VILLAGES AROUND ZAHAMENA PARK, SITE OF 1998-2003 COLLECTIONS
BEE KEEPING
ECOTOURISM INITIATIVE
IMPROVED CROPS
ECONOMIC DEVELOPMENT IN MADAGASCAR
SMALL-SCALE ECONOMIC DEVELOPMENT PROJECTS IN THE VILLAGES AROUND ZAHAMENA PARK, SITE OF 1998-2003 COLLECTIONS
BEE KEEPINGECOTOURISM INITIATIVEIMPROVED CROPS
INFRASTRUCTURE IMPROVEMENTS USING UPFRONT COMPENSATION FUNDS IN THE SAME VILLAGES
AGRICULTURAL WAREHOUSERENOVATION OF A PRIMARY SCHOOLCONSTRUCTION OF A FOOTBRIDGE